Cargando…
The cysteine proteinase inhibitor Z-Phe-Ala-CHN(2 )alters cell morphology and cell division activity of Trypanosoma brucei bloodstream forms in vivo
BACKGROUND: Current chemotherapy of human African trypanosomiasis or sleeping sickness relies on drugs developed decades ago, some of which show toxic side effects. One promising line of research towards the development of novel anti-trypanosomal drugs are small-molecule inhibitors of Trypanosoma br...
Autores principales: | Scory, Stefan, Stierhof, York-Dieter, Caffrey, Conor R, Steverding, Dietmar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1810305/ https://www.ncbi.nlm.nih.gov/pubmed/17328798 http://dx.doi.org/10.1186/1475-9292-6-2 |
Ejemplares similares
-
In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators
por: Merschjohann, Karin, et al.
Publicado: (2006) -
Trypanosoma brucei: trypanocidal and cell swelling activities of lasalocid acid
por: Steverding, Dietmar, et al.
Publicado: (2017) -
In vitro activity of salinomycin and monensin derivatives against Trypanosoma brucei
por: Steverding, Dietmar, et al.
Publicado: (2016) -
Cysteine eliminates the feeder cell requirement for cultivation of Trypanosoma brucei bloodstream forms in vitro
Publicado: (1985) -
Centromere-associated topoisomerase activity in bloodstream form Trypanosoma brucei
por: Obado, Samson O., et al.
Publicado: (2011)